|
Memantine
Study
This research will study if the drug Memantine (Namenda), which
is approved by the Food and Drug Administration (FDA) for use in
Alzheimer's disease, might also improve memory and thinking ability
in patients with HD. Memantine is not approved by the FDA for use
in HD. However, the FDA has approved the use of Memantine in this
study. Men or women aged 18 or older, who have been diagnosed with
HD and have current problems with memory or concentration will
be eligible to join this study. The study is being done at 3 sites
and will involve a total of 72 participants being followed for
6 months.
Faculty
Adam Rosenblatt, M.D.
Christopher Ross, M.D., Ph.D.
David Irani, M.D.
Staff
Abhijit Agarwal, M.B.B.S., M.P.H.
Barnett Shpritz, M.A.
Robin Miller, M.S.
Contact Information
Abhijit Agarwal, M.B.B.S., M.P.H.
600 North Wolfe Street, Meyer 2-181
Baltimore , MD 21287
Telephone: 410-955-1349
E-mail: aagarw11@jhmi.edu
|
 |
|
|
